Patent · US Active

Crystalline forms

US9340565B2 · kind B2 · utility

4Cited by

39References

20Claims

0Family size

Assignee

THAR PHARMACEUTICALS, INC. · US

Inventors

Mazen Hanna · Bradford, GB
Ning Shan · Tampa, US
Miranda L. Cheney · Tampa, US
David R. Weyna · Tampa, US
Paul K. Isbester · New York, US
Xufeng Sun · Shenyang, CN

Key dates

Filing date	Nov 23, 2011
Grant date	May 17, 2016
Priority date	—
Expiry date	Dec 14, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Preparation and characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl) phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.